- Investing Ideas
- /
- Global Buy the Dip
Global Buy the Dip
UPDATED May 06, 2024
Companies which may present a buying opportunity after a dip in share price.
2,789 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
RCEL | US$8.90 | 2.1% | -44.5% | US$229.6m | US$25.90 | PS4.6x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$5.16 | 13.3% | 4.8% | US$215.7m | US$19.00 | PS7.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
HHR | AU$0.007 | -12.5% | -78.1% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
ACI | ₹629.00 | -3.6% | 15.4% | ₹77.6b | ₹743.00 | PE19.5x | E29.0% | 0.3% | Materials | ||
CAI | AU$0.13 | -10.7% | -34.2% | AU$95.2m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
A036200 | ₩10,650.00 | -3.4% | 42.4% | ₩318.3b | ₩13,500.00 | PE17.5x | E38.6% | 0.8% | Semiconductors | ||
603688 | CN¥72.37 | -7.5% | -35.4% | CN¥26.1b | CN¥114.33 | PE6x | E28.9% | 9.7% | Semiconductors | ||
301358 | CN¥37.16 | 6.1% | -8.5% | CN¥28.1b | n/a | PE19.3x | E30.3% | 1.1% | Capital Goods | ||
NEWBRY | kr3.09 | -9.4% | -44.4% | kr75.0m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
SONM | US$0.56 | 9.8% | -39.8% | US$24.2m | US$2.00 | PB1.1x | E139.9% | n/a | Tech | ||
FTCI | US$0.53 | 19.2% | -79.8% | US$67.3m | n/a | PB1.1x | E63.1% | n/a | Capital Goods | ||
SEAPT | kr4.54 | -2.6% | -64.7% | kr1.6b | kr11.57 | PB0.9x | E54.2% | n/a | Energy | ||
KCB | KSh30.10 | 0.5% | -0.5% | KSh96.7b | KSh48.65 | PB0.4x | E26.0% | 0% | Banks | ||
A101390 | ₩7,440.00 | -4.9% | -27.1% | ₩67.1b | n/a | PB2.9x | E100.8% | n/a | Tech | ||
FXPO | UK£0.50 | -1.2% | -54.3% | UK£295.9m | UK£1.41 | PB0.3x | E116.3% | 0% | Materials | ||
300442 | CN¥30.25 | -3.7% | -5.3% | CN¥52.0b | CN¥36.36 | PE27.3x | E28.7% | 1.7% | Software | ||
DIGN | kr1.63 | 2.2% | -58.9% | kr114.9m | kr8.60 | PS1.3x | E139.0% | n/a | Healthcare | ||
CLBIO | kr10.25 | -2.8% | -42.9% | kr220.3m | kr29.00 | PS7.1x | E114.8% | n/a | Pharmaceuticals & Biotech | ||
FLNC | US$21.15 | 16.6% | 12.3% | US$3.8b | US$30.38 | PS1.2x | E65.2% | n/a | Capital Goods | ||
XBRANE | kr0.20 | -6.0% | -99.8% | kr311.2m | n/a | PS1.3x | E93.7% | n/a | Pharmaceuticals & Biotech | ||
OX2 | kr40.96 | 2.1% | -40.3% | kr11.2b | kr70.75 | PE12.7x | E29.9% | n/a | Capital Goods | ||
CABP | UK£1.40 | 5.3% | n/a | UK£355.8m | UK£1.78 | PE15.6x | E34.6% | n/a | Diversified Financials | ||
631 | HK$6.70 | 21.6% | -37.4% | HK$21.4b | HK$10.52 | PE10.2x | E21.2% | 2.8% | Capital Goods | ||
ARDX | US$9.15 | 41.6% | 118.4% | US$2.1b | US$13.83 | PS13.5x | E60.7% | n/a | Pharmaceuticals & Biotech |